National Human Genome Center of Shanghai Sees Company Born | GenomeWeb

NEW YORK, Sept. 4 - Shanghai IgCon Therapeutics, a joint venture of Genetastix and the South Gene Technology Company, got the official green light to begin operations from the Shanghai municipal government, the companies said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.